| scholarly article | Q13442814 |
| P2093 | author name string | Chia-Lin Wu | |
| Jiin-Haur Chuang | |||
| Ming-Huei Chou | |||
| Chih-Hsin Chen | |||
| Chang-Chun Hsiao | |||
| I-Hui Yang | |||
| Jong-Jer Lee | |||
| Yin-Chu Wei | |||
| P2860 | cites work | Upregulation of RAGE and its ligands in proliferative retinal disease | Q46858627 |
| High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo | Q48089403 | ||
| Interleukin-1alpha and HMGB1 mediate hippocampal dysfunction in SIGIRR-deficient mice. | Q51017414 | ||
| Vascular Endothelial Growth Factor Receptor-2 Activation Induces Vascular Permeability in Hyperstimulated Rats, and this Effect Is Prevented by Receptor Blockade | Q59593526 | ||
| The isolation and purification of the high mobility group (HMG) nonhistone chromosomal proteins | Q67601392 | ||
| The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas | Q71013356 | ||
| The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas | Q73556334 | ||
| Vascular endothelial growth factor and its receptors in control and diabetic rat eyes | Q77133548 | ||
| HMGb1 promotes scratch wound closure of HaCaT keratinocytes via ERK1/2 activation | Q84198876 | ||
| Deleterious role of anti-high mobility group box 1 monoclonal antibody in retinal ischemia-reperfusion injury | Q85096646 | ||
| HMGB1: endogenous danger signaling | Q24645232 | ||
| Biochemistry and molecular cell biology of diabetic complications | Q28131781 | ||
| HMGB1 loves company | Q28243671 | ||
| Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine | Q28505149 | ||
| The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system | Q28567291 | ||
| Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway | Q28571271 | ||
| Intraocular expression and release of high-mobility group box 1 protein in retinal detachment | Q28574646 | ||
| TIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphorylated upon ligand binding | Q28741936 | ||
| Toll-like receptor 2 mediates mesenchymal stem cell-associated myocardial recovery and VEGF production following acute ischemia-reperfusion injury | Q33840741 | ||
| High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism. | Q33869816 | ||
| Priming the nucleosome: a role for HMGB proteins? | Q35075720 | ||
| High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy | Q35108807 | ||
| The high-mobility group box-1 nuclear factor mediates retinal injury after ischemia reperfusion. | Q35519094 | ||
| Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1 | Q35659672 | ||
| Advanced glycation end-products and the progress of diabetic vascular complications. | Q35717287 | ||
| Expression of vascular endothelial growth factor in the human retina and in nonproliferative diabetic retinopathy. | Q35765120 | ||
| Nuclear heat shock protein 72 as a negative regulator of oxidative stress (hydrogen peroxide)-induced HMGB1 cytoplasmic translocation and release | Q35990434 | ||
| Oxidative stress-inducing carbonyl compounds from common foods: novel mediators of cellular dysfunction | Q36088078 | ||
| Diabetic retinopathy: mitochondrial dysfunction and retinal capillary cell death | Q36342647 | ||
| Diabetic retinopathy in a multi-ethnic cohort in the United States | Q36464921 | ||
| Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes | Q36842628 | ||
| The receptor RAGE: Bridging inflammation and cancer | Q37212720 | ||
| Advanced glycation end products increase retinal vascular endothelial growth factor expression | Q37379211 | ||
| The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. | Q38352705 | ||
| The DNA chaperone HMGB1 facilitates ACF/CHRAC-dependent nucleosome sliding | Q39693274 | ||
| HMGB1 develops enhanced proinflammatory activity by binding to cytokines. | Q40016396 | ||
| Activation of toll-like receptor 4 modulates vascular endothelial growth factor synthesis through prostacyclin-IP signaling | Q40083561 | ||
| Hexosamines and TGF-β1use similar signaling pathways to mediate matrix protein synthesis in mesangial cells | Q40626188 | ||
| Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities | Q42828870 | ||
| N-Acetylcysteine enhances the action of anti-inflammatory drugs as suppressors of prostaglandin production in monocytes | Q42982690 | ||
| Nifedipine inhibits advanced glycation end products (AGEs) and their receptor (RAGE) interaction-mediated proximal tubular cell injury via peroxisome proliferator-activated receptor-gamma activation | Q42989905 | ||
| Inhibitory effect of glycyrrhizin on the phosphorylation and DNA-binding abilities of high mobility group proteins 1 and 2 in vitro | Q43710889 | ||
| Effect of BSA-induced ER stress on SGLT protein expression levels and alpha-MG uptake in renal proximal tubule cells | Q46124638 | ||
| RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice | Q46142346 | ||
| P921 | main subject | endothelium | Q111140 |
| retinal ganglion cell | Q927337 | ||
| P304 | page(s) | 838-850 | |
| P577 | publication date | 2012-04-05 | |
| P1433 | published in | Molecular Vision | Q6895981 |
| P1476 | title | High-mobility group box 1 protein is implicated in advanced glycation end products-induced vascular endothelial growth factor A production in the rat retinal ganglion cell line RGC-5 | |
| P478 | volume | 18 |
| Q35273098 | Advanced glycation end products (AGEs) and their receptor (RAGE) induce apoptosis of periodontal ligament fibroblasts |
| Q47966996 | Advanced glycation end products impair K(Ca)3.1- and K(Ca)2.3-mediated vasodilatation via oxidative stress in rat mesenteric arteries |
| Q36610702 | Advanced glycation end-products stimulate basic fibroblast growth factor expression in cultured Müller cells |
| Q37180729 | Delineation of a de novo 7q21.3q31.1 Deletion by CGH-SNP Arrays in a Girl with Multiple Congenital Anomalies Including Severe Glaucoma. |
| Q38542115 | Diabetic Retinopathy: Vascular and Inflammatory Disease. |
| Q47758215 | EGHB010, a Standardized Extract of Paeoniae Radix and Glycyrrhizae Radix, Inhibits VEGF-Induced Tube Formation In Vitro and Retinal Vascular Leakage and Choroidal Neovascularization In Vivo |
| Q33990723 | ERK1/2/COX-2/PGE2 signaling pathway mediates GPR91-dependent VEGF release in streptozotocin-induced diabetes. |
| Q64958740 | HMBG1 as a Driver of Inflammatory and Immune Processes in the Pathogenesis of Ocular Diseases. |
| Q28066302 | High Mobility Group Box-1: A Missing Link between Diabetes and Its Complications |
| Q34746671 | Impact of GLO1 knock down on GLUT4 trafficking and glucose uptake in L6 myoblasts |
| Q34873489 | Lycium barbarum (wolfberry) reduces secondary degeneration and oxidative stress, and inhibits JNK pathway in retina after partial optic nerve transection. |
| Q38865936 | Neurodegeneration and Neuroinflammation in Diabetic Retinopathy: Potential Approaches to Delay Neuronal Loss. |
| Q85710201 | On authentication of cell lines |
| Q90053132 | Oxidative stress enhanced the transforming growth factor-β2-induced epithelial-mesenchymal transition through chemokine ligand 1 on ARPE-19 cell |
| Q42109750 | Redox status of high-mobility group box 1 performs a dual role in angiogenesis of colorectal carcinoma |
| Q35827577 | The MAPK signaling pathway mediates the GPR91-dependent release of VEGF from RGC-5 cells |
| Q27028225 | Vitreous mediators in retinal hypoxic diseases |
Search more.